Table 1.
n (%) | |
---|---|
Age | |
Mean (min-max) | 61.5 (31–86) |
| |
Stage | |
I/II | 1 (2.9) |
III | 27 (79.4) |
IV | 6 (17.6) |
| |
Histology | |
Serous | 24 (70.6) |
Endometrioid | 2 (5.9) |
Mixed | 3 (8.8) |
Other | 5 (14.7) |
| |
Tumor Grade | |
1 | 3 (8.8) |
2 | 1 (2.9) |
3 | 30 (88.2) |
| |
Pathologic Diagnosis | |
Ovarian | 27 (79.4) |
Fallopian tube | 1 (2.9) |
Primary peritoneal | 6 (17.6) |
| |
Performance Status | |
0 | 22 (64.7) |
1 | 12 (35.3) |
Prior # Chemotherapy Regimens | |
1 | 20 (58.8) |
2 | 14 (41.2) |
| |
Platinum-free Interval | |
<6 months | 12 (35.2) |
6–12 months | 11 (32.4) |
>12 months | 11 (32.4) |